Related Experiment Video
Updated: Jun 9, 2026
07:30
Learning Modern Laryngeal Surgery in a Dissection Laboratory
Published on: March 18, 2020
[Application of mitomycin in laryngeal surgery]
1Department of Otolaryngology, China-Japan Friendship Hospital, Beijing, 100029, China.
Summary
Mitomycin effectively prevents vocal cord adhesion following laryngeal surgery. This study shows fewer adhesions in patients treated with mitomycin compared to those without.
Area of Science:
- Otolaryngology
- Surgical Oncology
- Regenerative Medicine
Context:
- Vocal cord lesions, particularly those involving the anterior commissure, pose surgical challenges.
- Post-surgical adhesions can impair vocal function and necessitate further intervention.
- Mitomycin-C is an antineoplastic agent with antifibrotic properties.
Purpose:
- To evaluate the efficacy of topical mitomycin in preventing anterior commissure adhesions after laryngeal microsurgery.
- To compare surgical outcomes between patients treated with and without mitomycin.
Summary:
- A retrospective analysis of 48 patients with anterior commissure vocal cord lesions was conducted.
- 30 patients received microsurgery with topical mitomycin, while 18 underwent microsurgery alone.
- Adhesion rates were significantly lower in the mitomycin group (2/30) compared to the control group (6/18).
Impact:
- Topical mitomycin application demonstrates significant potential in reducing post-laryngeal surgery complications.
- This approach may improve functional outcomes and reduce the need for revision surgeries.
- Further prospective studies are warranted to confirm these findings and optimize treatment protocols.
